BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 21 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,000 | 0.0% | 1,350 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | -25.0% | 1,350 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | -20.0% | 1,350 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | +25.0% | 1,350 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | -92.5% | 1,350 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $53,000 | – | 1,350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRUE Private Wealth Advisors | 46,000 | $108,000 | 0.02% |
| TWO SIGMA SECURITIES, LLC | 49,440 | $116,000 | 0.01% |
| ExodusPoint Capital Management, LP | 31,500 | $74,000 | 0.00% |
| ROYAL BANK OF CANADA | 2,540 | $6,000 | 0.00% |
| UBS Group AG | 7,161 | $16,000 | 0.00% |
| NEXT Financial Group, Inc | 1,350 | $3,000 | 0.00% |
| CREDIT AGRICOLE S A | 4,240 | $10,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 200 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 13,768 | $32,000 | 0.00% |